Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Inflammatory bowel disease	6/65	4.391290107649152e-11	3.820422393654762e-09	203.61864406779662	-475.08782763230994	IL10;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Pertussis	6/76	1.1568130777763957e-10	5.032136888327322e-09	171.38571428571427	-430.8222663769055	IL10;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Tuberculosis	7/180	2.755110571231994e-10	7.989820656572783e-09	106.48362235067438	-315.2928367464337	IFNA1;IL10;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	African trypanosomiasis	5/37	3.773977645098542e-10	8.20840137808933e-09	251.125	-498.2497138339484	IL10;IL12B;IL1B;IL6;TNF
KEGG_2021_Human	Amoebiasis	6/102	7.046291742066198e-10	9.860115451955212e-09	124.5625	-348.54374361636394	IL10;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Chagas disease	6/102	7.046291742066198e-10	9.860115451955212e-09	124.5625	-348.54374361636394	IL10;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	6/104	7.933426225711089e-10	9.860115451955212e-09	121.98979591836735	-343.35038043058773	IFNA1;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Malaria	5/50	1.8221006146977156e-09	1.9815344184837657e-08	178.2888888888889	-399.8172378358562	IL10;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Legionellosis	5/57	3.5877996201909306e-09	3.4682062995178996e-08	154.15384615384616	-361.8273890688762	IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Leishmaniasis	5/77	1.6754970109672824e-08	1.3251658177650322e-07	111.05555555555556	-285.8634456707051	IL10;IL12B;IL1B;TLR4;TNF
KEGG_2021_Human	Influenza A	6/172	1.671886438631681e-08	1.3251658177650322e-07	71.40361445783132	-227.05657761700246	IFNA1;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Lipid and atherosclerosis	6/215	6.372447911498552e-08	4.62002473583645e-07	56.40430622009569	-186.7350241167357	IFNA1;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	5/104	7.689793164389816e-08	5.146246194630107e-07	80.4949494949495	-223.94034919826578	IL10;IL12B;IL1B;IL6;TNF
KEGG_2021_Human	Coronavirus disease	6/232	1.0038183269047773e-07	6.238013888622545e-07	52.04867256637168	-174.3857646205266	IFNA1;IL12B;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Yersinia infection	5/137	3.070399768694536e-07	1.7808318658428306e-06	60.121212121212125	-177.50304940933535	IL10;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Measles	5/139	3.301250436176135e-07	1.7950549246707736e-06	59.208955223880594	-175.30198917758304	IFNA1;IL12B;IL1B;IL6;TLR4
KEGG_2021_Human	Cytokine-cytokine receptor interaction	6/295	4.18613825458797e-07	2.1423178126420785e-06	40.37543252595156	-139.58751624866832	IFNA1;IL10;IL12B;IL1B;IL6;TNF
KEGG_2021_Human	Necroptosis	5/159	6.457403055921121e-07	3.1210781436952087e-06	51.38961038961039	-155.93286055355003	HMGB1;IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	5/181	1.2298084205616124e-06	5.631228030992646e-06	44.84090909090909	-138.94613864677578	IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Rheumatoid arthritis	4/93	3.2795638728842682e-06	1.4266102847046567e-05	59.767790262172284	-145.5024915816698	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Toxoplasmosis	4/112	6.897261761044327e-06	2.8574370152897924e-05	49.135802469135804	-124.17448810278691	IL10;IL12B;TLR4;TNF
KEGG_2021_Human	Allograft rejection	3/38	1.1267399953362688e-05	4.455744527011608e-05	98.36326530612244	-155.5765022451814	IL10;IL12B;TNF
KEGG_2021_Human	Graft-versus-host disease	3/42	1.5293149491516165e-05	5.7848000250517664e-05	88.23076923076923	-143.80928698800247	IL1B;IL6;TNF
KEGG_2021_Human	Type I diabetes mellitus	3/43	1.6429423914376138e-05	5.95566616896135e-05	86.01428571428572	-141.158089869663	IL12B;IL1B;TNF
KEGG_2021_Human	JAK-STAT signaling pathway	4/162	2.979383554686203e-05	9.969475740680756e-05	33.37552742616034	-89.36652156273904	IFNA1;IL10;IL12B;IL6
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	9.969475740680756e-05	33.37552742616034	-89.36652156273904	IFNA1;IL6;TLR4;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	3/63	5.21817057256637e-05	0.00016814105178269414	57.2	-103.63746645388204	IFNA1;IL1B;IL6
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.00019953732990355842	27.202072538860104	-74.37625984844887	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	3/70	7.160249860764975e-05	0.00021480749582294926	51.17910447761194	-94.92366080084827	IFNA1;IL12B;TNF
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.000312781654817226	23.671191553544496	-65.36509727839072	IFNA1;IL1B;IL6;TNF
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.0004486247613939823	21.287074829931974	-59.07439560833883	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	5/498	0.00016972194719545373	0.00045505907323996206	15.365111561866126	-50.06173980977876	IFNA1;IL12B;IL1B;IL6;TNF
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.00045505907323996206	37.56828885400314	-73.71479219141467	IL1B;IL6;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0005012315314023066	35.2179675994109	-69.8003308229761	IL1B;IL6;TNF
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.0005012315314023066	35.589285714285715	-70.42440314178907	IL1B;IL6;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	3/100	0.00020740615092509237	0.0005012315314023066	35.2179675994109	-69.8003308229761	IL10;IL6;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.0005477881913201392	33.806223479490804	-67.40758155759835	IL1B;TLR4;TNF
KEGG_2021_Human	TNF signaling pathway	3/112	0.00029005838446074546	0.0006640810381074962	31.293577981651374	-63.06696788213405	IL1B;IL6;TNF
KEGG_2021_Human	Asthma	2/31	0.0006292457268839483	0.0014037020061257307	69.30172413793103	-73.992829918215	IL10;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.001638031754947773	22.31954887218045	-46.57552582678881	IL1B;IL6;TNF
KEGG_2021_Human	Intestinal immune network for IgA production	2/48	0.0015093757711636376	0.003202821758322841	43.59782608695652	-51.89779709972968	IL10;IL6
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0016236545858167558	0.0033632844991918513	16.946877243359655	-35.79178563433967	IFNA1;IL6;TNF
KEGG_2021_Human	Proteoglycans in cancer	3/205	0.0016941022902244062	0.00342760230812845	16.68882602545969	-35.25303962280841	IL12B;TLR4;TNF
KEGG_2021_Human	Autoimmune thyroid disease	2/53	0.0018378173017361363	0.0036074848074978396	39.299019607843135	-47.75438384041307	IFNA1;IL10
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.0036074848074978396	16.115516062884485	-34.04865723073064	IFNA1;TLR4;TNF
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.005402448180855334	13.800705467372135	-29.076248648200146	IL1B;TLR4;TNF
KEGG_2021_Human	Prion disease	3/273	0.0038397781028777236	0.007107674360645999	12.377777777777778	-25.926933584065353	IL1B;IL6;TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.009447385021356818	22.670454545454547	-29.92662218019896	IL6;TNF
KEGG_2021_Human	Staphylococcus aureus infection	2/95	0.005791844483948442	0.010283478981704378	21.438172043010752	-28.45964210186145	CFH;IL10
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.012017135005009326	19.524509803921568	-26.130280011490946	IL10;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.012417637180748706	18.95952380952381	-25.42995427691617	IL1B;IL6
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.012417637180748706	18.778301886792452	-25.204052222837845	IL6;TNF
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.012417637180748706	18.600467289719628	-24.98176436194636	IL6;TLR4
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.012817019583760041	9.422466422466423	-19.140881053489387	IFNA1;IL6;TLR4
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.014116232210466387	9.018735362997658	-18.187178129854335	IL1B;IL6;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.01578634313694345	15.886	-21.510038502238015	IL1B;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.016178309540357576	15.385658914728682	-20.853034219946885	IFNA1;TNF
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.016178309540357576	15.385658914728682	-20.853034219946885	IL10;IL6
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.016849390625764064	14.915413533834586	-20.230385574789178	IL10;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.01752231198582482	14.472627737226277	-19.639406588988233	IL1B;TNF
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.021745676810856304	12.762903225806452	-17.312716751580805	IFNA1;TNF
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.024938362425988143	6.897094430992736	-13.07371705691191	IL1B;IL6;TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.02990644616374101	10.536096256684491	-14.167050995225416	HMGB1;TLR4
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.030620696657233958	10.31020942408377	-13.840129933766221	IFNA1;IL6
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.03203315585978693	6.12012987012987	-11.164029011261546	IFNA1;IL12B;IL6
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.03760303576069152	9.044930875576037	-11.980722307867735	IL6;TNF
KEGG_2021_Human	Base excision repair	1/33	0.040130782413471976	0.05211012044734421	27.90277777777778	-15.299431750604054	HMGB1
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.06266429529497483	6.657534246575342	-8.337786615237395	IL1B;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.07002575125439073	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.0753225074480891	5.880699088145897	-7.115618067766183	IFNA1;TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.09938158837662792	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.09938747086614762	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.11026178792817065	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Complement and coagulation cascades	1/85	0.10043221696214563	0.11807571453657663	10.56084656084656	-6.37671991533167	CFH
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.12171461895695417	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.12395640665725316	9.739926739926739	-5.8737398650795125	IL12B
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.12486838572375442	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.12575137133869932	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.12660647561469202	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.15006832693697736	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.16895454814091188	6.480392156862745	-3.763669230249352	HMGB1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.1725109045548893	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.18143159714807222	5.672401433691756	-3.209640069203435	IL6
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.18143159714807222	5.82560706401766	-3.3156870475343334	TLR4
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.18143159714807222	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.21640095537816492	4.5823152995927865	-2.441961042053517	IL6
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
